An Example of 5-exo versus 5-endo Cyclization Governed by the Electrophile
Dowex 50 W/Hϩ acid resin (10.50 g) was added and the suspension (731 mg). This mixture was separated by radial chromatography
FULL PAPER
was stirred at room temperature for 2 h. The resin was filtered off,
and the filtrate was purified by column chromatography, to obtain
5.88 g of 5a (100%) as a syrup. Ϫ [α]2D5 ϭ ϩ46.6 (CHCl3, c ϭ 0.81).
(hexane with 1% of methanol). Finally, compounds 7a (625 mg,
71%) and 9a (106 mg, 12%) were isolated as syrups.
1
Compound 7a: [α]2D5 ϭ ϩ26.5 (CHCl3, c ϭ 1.60). Ϫ H NMR: δ ϭ
1
Ϫ H NMR: δ ϭ 2.50Ϫ3.10 (br. s, 2 H), 3.60Ϫ3.80 (m, 3 H), 3.89
2.41 (d, 1 H, J ϭ 4.5), 3.56 (dd, 1 H, J ϭ 9.8, 6.0), 3.62 (dd, 1 H,
J ϭ 9.8, 4.0), 3.86 (tt, 1 H, J ϭ 6.7, 0.8), 3.91 (br. s, 1 H), 4.37 (d,
1 H, J ϭ 11.7), 4.54 (s, 2 H), 4.62 (d, 1 H, J ϭ 11.7), 5.34 (ddd, 1
H, J ϭ 17.3, 1.8, 0.9), 5.40 (ddd, 1 H, J ϭ 10.4, 1.8, 0.7), 5.86
(ddd, 1 H, J ϭ 17.3, 10.4, 7.6), 7.20Ϫ7.40 (m, 10 H). Ϫ 13C NMR:
δ ϭ 70.2, 70.6, 72.2, 73.3, 80.7, 120.1, 127.6, 127.7, 127.8, 127.8,
128.4, 128.4, 135.0, 138.0, 138.1. Ϫ C19H22O3 (298.38): calcd. C
76.41, H 7.43; found C 76.37, H 7.51.
(dd, 1 H, J ϭ 7.7, 4.0), 4.36 (d, 1 H, J ϭ 11.7), 4.63 (d, 1 H, J ϭ
11.7), 5.36 (dt, 1 H, J ϭ 17.3, 0.9), 5.40 (dt, 1 H, J ϭ 10.4, 0.8),
5.82 (ddd, 1 H, J ϭ 17.3, 10.4, 7.7), 7.35 (m, 5 H). Ϫ 13C NMR:
δ ϭ 63.1, 70.6, 73.1, 82.0, 120.2, 127.8 (2 C), 128.4, 134.8, 137.7. Ϫ
C12H16O3 (208.26): calcd. C 69.21, H 7.74; found C 69.40, H 7.84.
(2R,3R)-3-O-Benzyl-4-pentene-1,2,3-triol (5b): This compound was
prepared according to the same procedure as for 5a, starting from
compound 3b (4.01 g, 16.14 mmol), dry methanol (25 mL), and
Dowex 50 W/Hϩ acid resin (6.40 g). After purification, 5b (3.36 g,
100%) was recovered. Ϫ [α]2D5 ϭ Ϫ40.6 (CHCl3, c ϭ 0.47). Ϫ 1H
NMR: δ ϭ 2.80 (br. s, 1 H), 3.00 (br. s, 1 H), 3.50Ϫ3.80 (m, 3 H),
3.84 (t, 1 H, J ϭ 7.7), 4.34 (d, 1 H, J ϭ 11.5), 4.65 (d, 1 H, J ϭ
11.5), 5.37 (ddd, 1 H, J ϭ 16.8, 1.6, 0.8), 5.39 (ddd, 1 H, J ϭ 11.0,
1.6, 0.6), 5.77 (ddd, 1 H, J ϭ 16.8, 11.0, 7.7), 7.20Ϫ7.40 (m, 5 H).
1
Compound 9a: [α]2D5 ϭ ϩ45.6 (CHCl3, c ϭ 1.72). Ϫ H NMR: δ ϭ
2.20Ϫ2.40 (br. s, 1 H), 3.55 (dd, 1 H, J ϭ 5.6, 10.0), 3.70Ϫ3.80 (br.
s, 2 H), 3.98 (dd, 1 H, J ϭ 7.5, 5.6), 4.40 (d, 1 H, J ϭ 11.8), 4.59
(d, 1 H, J ϭ 11.6), 4.66 (d, 1 H, J ϭ 11.8), 4.69 (d, 1 H, J ϭ 11.6),
5.37 (ddd, 1 H, J ϭ 17.0, 1.8, 0.8), 5.39 (ddd, 1 H, J ϭ 10.7, 1.8,
0.8), 5.87 (ddd, 1 H, J ϭ 17.0, 10.7, 7.5), 7.20Ϫ7.40 (m, 10 H). Ϫ
13C NMR: δ ϭ 61.8, 70.5, 72.6, 80.7, 81.0, 119.5, 127.7, 127.8,
128.0 (2 C), 128.5 (2 C), 135.6, 138.1, 138.1. Ϫ C19H22O3 (298.38):
calcd. C 76.41, H 7.43; found C 76.32, H 7.55.
Ϫ
13C NMR: δ ϭ 62.9, 70.4, 73.8, 81.3, 120.7, 127.9, 128.0, 128.5,
134.5, 137.5. Ϫ C12H16O3 (208.26): calcd. C 69.21, H 7.74; found
C 69.05, H 7.80.
(2R,3R)-1,3-Di-O-benzyl-4-pentene-1,2,3-triol (7b): The procedure
followed was the same as that for the synthesis of 7a, using diol 5b
(383 mg, 1.84 mmol), toluene (45 mL), 4-A molecular sieves
(2R,3S)-3-O-tert-Butyldiphenylsilyl-4-pentene-1,2,3-triol (6a): A so-
lution of dilute hydrochloric acid in ethanol (65 mL, 1 mL of con-
centrated HCl per 100 mL of ethanol) was added to compound 4a
(265 mg, 0.67 mmol). The reaction was complete after 3 h. The
excess of acid was neutralized by adding 1 mL of aqueous NH3,
and the solvent was removed in vacuo. The product was purified
by column chromatography (hexane/ethyl acetate, 2:1), and diol 6a
(216 mg, 91%) was obtained as a syrup. Ϫ [α]2D5 ϭ Ϫ4.84 (CHCl3,
˚
(4.00 g), dibutyltin oxide (595 mg, 2.39 mmol), benzyl bromide (370
µL, 3.12 mmol), and tetrabutylammonium bromide (664 mg,
1.84 mmol). Purification was carried out in an MPLC apparatus,
using a linear gradient [hexane to hexane/ethyl acetate (3:1)], to
obtain 368 mg of 7b (67%) as a syrup. Ϫ [α]2D5 ϭ Ϫ28.6 (CHCl3,
1
c ϭ 1.74). Ϫ H NMR: δ ϭ 2.64Ϫ2.92 (br. s, 1 H), 3.48 (dd, 1 H,
1
c ϭ 2.65). Ϫ H NMR: δ ϭ 1.08 (s, 9 H), 2.35 (br. s, 1 H), 2.53
J ϭ 10.0, 5.7), 3.58 (dd, 1 H, J ϭ 10.0, 3.9), 3.78 (td, 1 H, J ϭ 6.1,
3.8), 3.92 (t, 1 H, J ϭ 7.2), 4.36 (d, 1 H, J ϭ 11.4), 4.49 (d, 1 H,
J ϭ 12.0), 4.55 (d, 1 H, J ϭ 12.0), 4.63 (d, 1 H, J ϭ 11.4), 5.34
(ddd, 1 H, J ϭ 9.8, 1.5, 0.8), 5.34 (ddd, 1 H, J ϭ 17.9, 1.5, 0.8),
5.78 (ddd, 1 H, J ϭ 17.9, 9.8, 7.9), 7.30 (m, 10 H). Ϫ 13C NMR:
δ ϭ 70.3, 70.4, 72.8, 73.4, 80.7, 119.9, 127.7, 127.7, 127.8, 127.8,
127.9, 128.4, 128.4, 134.9, 138.0. Ϫ C19H22O3 (298.38): calcd. C
76.41, H 7.43; found C 76.19, H 7.52.
(br. s, 1 H), 3.60Ϫ3.70 (m, 3 H), 4.19 (ddt, 1 H, J ϭ 7.1, 3.9, 1.2),
4.94 (dt, 1 H, J ϭ 17.2, 1.2), 5.04 (dt, 1 H, J ϭ 10.4, 1.3), 5.79
(ddd, 1 H, J ϭ 17.2, 10.4, 7.1), 7.30Ϫ7.80 (m, 10 H). Ϫ 13C NMR:
δ ϭ 19.2, 26.9, 63.0, 74.5, 76.7, 118.0, 127.6, 127.8, 129.9, 130.1,
133.3, 133.2, 135.9, 136.1, 136.5. Ϫ C21H28O3Si (356.54): calcd. C
70.74, H 7.92; found C 70.84, H 8.06.
(2R,3R)-3-O-tert-Butyldiphenylsilyl-4-pentene-1,2,3-triol (6b): The
procedure used was identical to the one above, starting from com-
pound 4b (249 mg, 0.63 mmol) and a dilute solution of HCl in
ethanol (65 mL). After the workup and flash chromatography (hex-
ane/ethyl acetate, 2:1), diol 6b (202 mg, 90%) was recovered. Ϫ [α]
(2R,3S)-3-O-Benzyl-1-O-tert-butyldiphenylsilyl-4-pentene-1,2,3-triol
(8a): The diol 5a (264 mg, 1.27 mmol) was treated under the gen-
eral conditions for silylation. TLC monitoring showed that the
starting material was consumed in 50 min. The crude silyl ether
was recovered as usual and purified by column chromatography
(hexane/ethyl acetate, 10:1), to afford 537 mg of 8a (95%) as a
25 ϭ ϩ15.7 (CHCl3, c ϭ 2.64). Ϫ 1H NMR: δ ϭ 1.08 (s, 9 H), 2.04
D
(br. s, 1 H), 2.61 (br. s, 1 H), 3.50 (dd, 1 H, J ϭ 12.0, 6.9), 3.60Ϫ3.70
(m, 2 H), 4.19 (ddt, 1 H, J ϭ 7.3, 5.8, 1.3), 4.96 (dt, 1 H, J ϭ 17.3,
1.3), 5.02 (dt, 1 H, J ϭ 10.4, 1.3), 5.80 (ddd, 1 H, J ϭ 17.3, 10.4,
7.3), 7.30Ϫ7.80 (m, 10 H). Ϫ 13C NMR: δ ϭ 19.2, 26.9, 62.7, 74.7,
75.8, 117.8, 127.5, 127.7, 129.8, 129.9, 133.3, 135.8, 136.0, 136.6.
Ϫ C21H28O3Si (356.54): calcd. C 70.74, H 7.92; found C 70.86,
H 8.09.
1
syrup. Ϫ [α]2D5 ϭ ϩ4.9 (CHCl3, c ϭ 1.75). Ϫ H NMR: δ ϭ 1.01
(s, 9 H), 2.42 (d, 1 H, J ϭ 4.3 Hz), 3.06Ϫ3.80 (m, 3 H), 3.90 (dd,
1 H, J ϭ 7.7, 5.4), 4.33 (d, 1 H, J ϭ 11.8), 4.60 (d, 1 H, J ϭ 11.8),
5.32 (ddd, 1 H, J ϭ 17.2, 1.8, 0.9), 5.37 (ddd, 1 H, J ϭ 10.4, 1.8,
0.6), 5.85 (ddd, 1 H, J ϭ 17.2, 10.4, 7.7), 7.10Ϫ7.70 (m, 15 H). Ϫ
13C NMR: δ ϭ 19.1, 26.7, 64.3, 70.3, 73.4, 80.7, 119.8, 127.6, 127.8
(2 C), 128.4, 129.8 (2 C), 133.2, 135.2, 135.6 (2 C), 136.0, 138.2.
Ϫ C28H34O3Si (446.66): calcd. C 75.29, H 7.67; found C 75.42,
H 7.53.
(2R,3S)-1,3-Di-O-benzyl-4-pentene-1,2,3-triol (7a) and (2R,3S)-2,3-
Di-O-benzyl-4-pentene-1,2,3-triol (9a): To a solution of diol 5a
˚
(612 mg, 2.94 mmol) in toluene (75 mL) were added 4-A molecular
sieves (6.00 g) and dibutyltin oxide (951 mg, 3.82 mmol). The mix-
ture was heated at 110 °C for 2 d, removing water with a Dean-
Stark apparatus. Then, BnBr (600 µL, 5.05 mmol) and tetrabu-
(2R,3R)-3-O-Benzyl-1-O-tert-butyldiphenylsilyl-4-pentene-1,2,3-
triol (8b): Diol 5b (255 mg, 1.22 mmol) was treated under the gen-
eral conditions for silylation. After flash chromatography, 452 mg
tylammonium bromide (1.06 g, 2.94 mmol) were added, and the of the silyl ether 8b (83%) was obtained as a syrup. Ϫ [α]2D5 ϭ Ϫ19.6
1
mixture was stirred at 70°C for two more days. The solvent was
removed under vacuum, the molecular sieves were filtered off and
the residue was purified by MPLC using a linear gradient [hexane
to hexane/ethyl acetate (2:1)], to afford compounds 7a and 9a
(CHCl3, c ϭ 1.70). Ϫ H NMR: δ ϭ 1.04 (s, 9 H), 2.64 (d, 1 H,
J ϭ 4.5), 3.60Ϫ3.80 (m, 2 H), 3.77 (dd, 1 H, J ϭ 11.4, 6.3), 4.01
(ddt, 1 H, J ϭ 7.9, 5.1, 0.8), 4.37 (d, 1 H, J ϭ 11.6), 4.65 (d, 1 H,
J ϭ 11.6), 5.32 (ddd, 1 H, J ϭ 10.4, 1.8, 0.8), 5.33 (ddd, 1 H, J ϭ
Eur. J. Org. Chem. 2001, 507Ϫ516
513